Key result
Recently diagnosed asymptomatic sarcoidosis shows no difference in CMR-derived GLS versus healthy controls.
Why the study?
Sarcoidosis affects various organs including the heart, and whether CMR feature tracking strain analysis can detect early cardiac involvement in asymptomatic patients remained to be assessed.
Does CMR strain analysis using feature tracking detect early cardiac involvement in asymptomatic patients with sarcoidosis compared to controls?
Observational (n=132)
No
Does CMR strain analysis using feature tracking detect early cardiac involvement in asymptomatic patients with sarcoidosis compared to controls?
CMR feature tracking derived global strain did not show differences in myocardial deformation between asymptomatic patients with sarcoidosis and healthy controls.
Answers are grounded in this paper and cite their sources.
Does not support CMR feature tracking for early detection in asymptomatic sarcoidosis; leaves open its role in longitudinal or higher-risk assessment.
BACKGROUND: Sarcoidosis is a systemic granulomatous disease affecting different organs including the heart. Myocardial strain analysis could potentially detect the early stages of cardiac dysfunction in sarcoidosis patients. The present study aims to assess the use of cardiac magnetic resonance (CMR) strain analysis using feature tracking (FT) in the detection of early cardiac involvement in asymptomatic patients with sarcoidosis. METHODS: One hundred and thirteen CMR studies of patients with sarcoidosis of the respiratory tract and/or extrapulmonary sarcoidosis without pre-existing known cardiovascular disease were included in the study and analysed using FT and compared to 22 age and gender-matched controls. Global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) of the left ventricle (LV) were measured. RESULTS: The sarcoidosis patients did not significantly differ from the controls in basic demographic data and had normal global and regional systolic LV function-LV ejection fraction (EF) 66 ± 7% vs 65 ± 5% in the controls (p = NS). No statistically significant differences were found in all strain parameters between patients and controls: GLS (- 13.9 ± 3.1 vs. - 14.2 ± 2.5), GCS (- 23.4 ± 4.0 vs. - 22.2 ± 2.9) and GRS (53.4 ± 13.5 vs. 51.2 ± 13.6%) (p = NS). CONCLUSION: Patients with sarcoidosis of the respiratory tract and/or extrapulmonary sarcoidosis had normal myocardial deformation measured by CMR-FT derived global strain.
No takes yet. Share an insight, caveat, or question.
Panovský et al. (2021) conducted an observational in Sarcoidosis of the respiratory tract and/or extrapulmonary sarcoidosis (n=132). Cardiac magnetic resonance feature tracking (CMR-FT) vs. Healthy controls was evaluated on Global longitudinal strain (GLS) (p=0.68). Cardiac magnetic resonance feature tracking revealed no significant differences in global longitudinal strain between asymptomatic patients with recently diagnosed sarcoidosis and healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: